Jane Street’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
RI
VCM
SB
Jane Street's AQST Position: Q1 2026 in Review
Jane Street increased its Aquestive Therapeutics (AQST) stake by 101% in Q1 2026, buying an estimated $2.1M and bringing the position to 1,030,050 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3736.
Jane Street first reported a position in AQST in Q2 2019 and has held it in 16 quarters since. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.
- Jane Street held 1,030,050 shares of Aquestive Therapeutics worth $4.27M as of Q1 2026.
- Jane Street bought 517,830 Aquestive Therapeutics shares in Q1 2026, an estimated $2.1M.
- Aquestive Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3736 holding.
- Jane Street first reported a position in Aquestive Therapeutics in Q2 2019 and has held it in 16 quarters since.
- 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.